Physician profile
James Bewley
NPI 1639257017
$4,493.73
in general payments reported to CMS, 2019-2025
15 companies · $793 in 2025
The $793 reported for 2025 was more than what 87% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $908 · 2020: $379 · 2021: $643 · 2022: $250 · 2023: $770 · 2024: $751 · 2025: $793.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,295 · Entertainment: $18.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,295.04 |
| Entertainment | $18.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,224.85 | 2019-2025 | Precision 1, Total30, Ngenuity |
| Glaukos Corporation | $567.68 | 2024-2025 | Idosetr, Istent Infinite |
| Lkc Technologies, INC. | $393.04 | 2023-2024 | |
| Bausch & Lomb Americas INC. | $239.23 | 2022-2025 | Vyzulta, Lotemax Sm, Envista Mx60 Iol |
| Biotissue Holdings INC. | $204.68 | 2023-2025 | |
| Allergan, INC. | $199.54 | 2020-2021 | |
| Sight Sciences, INC. | $183.02 | 2021 | |
| Coopervision INC. | $161.99 | 2024-2025 | Clariti Contact Lens, Misight Contact Lens |
| Sun Pharmaceutical Industries INC. | $96.50 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $66.47 | 2019-2023 | Acuvue |
| Abbvie INC. | $54.28 | 2022-2025 | |
| Rxsight INC | $44.47 | 2024-2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Light Adjustable Lens (Lal) |
| Kala Pharmaceuticals, INC. | $23.87 | 2022 | |
| Optos, INC. | $18.42 | 2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Johnson & Johnson Surgical Vision, INC. | $15.69 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Bewley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.